West Nile Virus Infections-Pipeline Insights, 2016

Transcription

1 Brochure More information from West Nile Virus Infections-Pipeline Insights, 2016 Description: West Nile Virus Infections-Pipeline Insights, 2016 provides in depth insight on the pipeline drugs and their development activities around the West Nile Virus Infections. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. The Report covers the product clinical trials information and other development activities including technology, licensing, collaboration, acquisitions, funding, patent and USFDA & EMA designations details. The Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for West Nile Virus Infections. The report also assesses the West Nile Virus Infections therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. Scope - The report provides competitive pipeline landscape of West Nile Virus Infections - The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information - Coverage of the West Nile Virus Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report review the key players involved in the therapeutics development for West Nile Virus Infections and also provides company profiling - The report also gives the information on dormant and discontinued pipeline projects - Pipeline products coverage based on various stages of development ranging from pre registration till discovery and undisclosed stages - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type Reasons to buy - Complete Pipeline intelligence and complete understanding over therapeutic development for West Nile Virus Infections - Identify the relationship between the drugs and its use for target finding, drug repurposing, and precision medicine. - Devise corrective measure for pipeline projects by understanding West Nile Virus Infections pipeline depth and focus of Indication therapeutics - Developing strategic initiatives to support your drug development activities. - Optimizing the portfolio and keep in touch with the rapid changing pharmaceutical market, and make the best decision for your business. - Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Provides strategically significant competitor information, analysis, and insight to formulate effective R&D development strategies - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline - Gaining a clear picture of the competitive landscape for evidence based decisions Contents: - West Nile Virus Infections Overview - West Nile Virus Infections Pipeline Therapeutics - West Nile Virus Infections Therapeutics under Development by Companies - West Nile Virus Infections Filed and Phase III Products - West Nile Virus Infections Phase II Products - West Nile Virus Infections Phase I and IND Filed Products - West Nile Virus Infections Discovery and Pre-Clinical Stage Products

2 - Drug Candidate Profiles - West Nile Virus Infections Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - West Nile Virus Infections Discontinued Products - West Nile Virus Infections Dormant Products - Companies Involved in Therapeutics Development for West Nile Virus Infections - Appendix - Methodology - Contact Us - Disclaimer List of Tables - Number of Products under Development for West Nile Virus Infections, Number of Products under Development by Companies by Filed and Phase III Products, 2016 Phase II Products, 2016 Phase I and IND Filed Products, 2016 Discovery and Pre-Clinical Stage Products, Drug Candidates Profiles - West Nile Virus Infections Assessment by Monotherapy Products - West Nile Virus Infections Assessment by Combination Products - West Nile Virus Infections Assessment by Route of Administration - West Nile Virus Infections Assessment by Stage and Route of Administration - West Nile Virus Infections Assessment by Molecule Type - West Nile Virus Infections Assessment by Stage and Molecule Type - West Nile Virus Infections Therapeutics Discontinued Products - West Nile Virus Infections Therapeutics Dormant Products - Products under Development by Companies, 2016 List of Figures - Number of Products under Development for West Nile Virus Infections, Filed and Phase III Products, Phase II Products, Phase I and IND Filed Products, Discovery and Pre-Clinical Stage Products, West Nile Virus Infections Assessment by Monotherapy Products - West Nile Virus Infections Assessment by Combination Products - West Nile Virus Infections Assessment by Route of Administration - West Nile Virus Infections Assessment by Stage and Route of Administration - West Nile Virus Infections Assessment by Molecule Type - West Nile Virus Infections Assessment by Stage and Molecule Type Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8,

3

4 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: West Nile Virus Infections-Pipeline Insights, 2016 Web Address: Office Code: Product Formats Please select the product formats and quantity you require: SC Single User: Site License: Enterprisewide: Quantity USD 1250 USD 2500 USD 4000 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

5 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World